FEBS Letters · 1997 · 356 citations · 7 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMycologyAntibiotic ResistanceAntifungal AgentsAntifungal ResistanceFungal InfectionsFungal PathogenesisMechanisms Of Antimicrobial ResistanceAntifungal Drug ResistanceAntifungal Resistance MechanismsAzole ResistanceCandida Albicans InfectionCandidiasis Drug ResistanceFluconazole TherapyFungal Drug ResistanceResistance In Clinical Isolates
Fluconazole resistance occurs in > 10% of cases of candidosis during the late stages of AIDS. We show here in two clinical isolates that resistance was caused by defective sterol delta5,6-desaturation. This altered the type of sterol accumulating under fluconazole treatment from 14alpha-methylergosta-8,24(28)-dien-3beta,6alpha -diol to 14alpha-methylfecosterol which is capable of supporting growth. A consequence of this mechanism of azole resistance is that an absence of ergosterol causes cross-resistance to the other major antifungal agent available, amphotericin B. The results also show that growth arrest after fluconazole treatment of C. albicans in clinical conditions is caused by 14alpha-methylergosta-8,24(28)-dien-3beta,6alpha -diol accumulation.
7
Dominique Sanglard, Karl Kuchler, Françoise Ischer et al. · Antimicrobial Agents and Chemotherapy · 1995 · 817 citations
Steven L. Kelly, David C. Lamb, Andrew J. Corran et al. · Biochemical and Biophysical Research Communications · 1995 · 297 citations
Polyene antibiotic - sterol interaction.
Anthony W. Norman, Anna M. Spielvogel, Richard G. Wong · PubMed · 1976 · 185 citations
Fluconazole-resistant candidosis in an HIV cohort
Guy Baily, Fiona Perry, David W. Denning et al. · AIDS · 1994 · 131 citations